Editor's Highlights—March 2025
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17676 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Lajos Kemény. Beteiligte Einrichtung: Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Psoriasis, Hidradenitis Suppurativa, Dermatitis, Atopic, Janus Kinase Inhibitors. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Managing chronic inflammatory skin diseases such as hidradenitis suppurativa (HS) and psoriasis extends beyond clinical measures; it should also consider patient‐reported outcomes, treatment burden, and overall satisfaction. Successful therapy in both conditions is influenced by factors such as residual disease activity, the psychological profiles of patients, and the availability of new treatment options. The coexistence of psoriasis and atopic dermatitis can pose significant diagnostic and therapeutic challenges. In such rare cases, Janus kinase inhibitors may be considered a treatment option instead of biologics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
ORCID-Profile: Lajos Kemény
Zitieren
APA
Kemény, L. (2025). Editor's Highlights—March 2025. International Journal of Dermatology. https://doi.org/10.1111/ijd.17676
Vancouver
Kemény L. Editor's Highlights—March 2025. International Journal of Dermatology. 2025. doi:10.1111/ijd.17676
BibTeX
@article{Kemny2025,
author = {Kemény, Lajos},
title = {Editor's Highlights—March 2025},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17676}
}
EUVIMED